Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 1
2012 1
2013 1
2014 2
2015 1
2016 1
2019 2
2020 4
2021 2
2022 2
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Metastatic Malignant Neoplasm in the Anus"
Page 1
Meta-analysis of neoadjuvant immunotherapy for non-metastatic colorectal cancer.
Zhou L, Yang XQ, Zhao GY, Wang FJ, Liu X. Zhou L, et al. Front Immunol. 2023 Jan 27;14:1044353. doi: 10.3389/fimmu.2023.1044353. eCollection 2023. Front Immunol. 2023. PMID: 36776899 Free PMC article.
BACKGROUND: Immunotherapy has been approved for the treatment of metastatic colorectal cancer. The efficacy and safety of neoadjuvant immunotherapy for the treatment of non-metastatic colorectal cancer remains unclear. ...Neoadjuvant immunotherapy could be another t …
BACKGROUND: Immunotherapy has been approved for the treatment of metastatic colorectal cancer. The efficacy and safety of neoadjuvant …
A systematic review and meta-analysis of mortality in anal cancer patients by HIV status.
Sumner L, Kamitani E, Chase S, Wang Y. Sumner L, et al. Cancer Epidemiol. 2022 Feb;76:102069. doi: 10.1016/j.canep.2021.102069. Epub 2021 Dec 2. Cancer Epidemiol. 2022. PMID: 34864578 Review.
As a result of increased survival times, diagnosis of non-AIDS-defining cancers, including anal cancer (AC), has increased among PWH. The purpose of this meta-analysis was to determine if PWH have a higher hazard of mortality compared to non-PWH following AC diagnosis in t …
As a result of increased survival times, diagnosis of non-AIDS-defining cancers, including anal cancer (AC), has increased among PWH. …
Prognostic biomarkers in squamous cell carcinoma of the anus: a systematic review.
Lampejo T, Kavanagh D, Clark J, Goldin R, Osborn M, Ziprin P, Cleator S. Lampejo T, et al. Br J Cancer. 2010 Dec 7;103(12):1858-69. doi: 10.1038/sj.bjc.6605984. Epub 2010 Nov 9. Br J Cancer. 2010. PMID: 21063399 Free PMC article. Review.
BACKGROUND: recent decades have seen combination chemoradiotherapy become the standard treatment for anal squamous cell carcinoma (SCC). However, the burden of this disease continues to rise, with only 10% of patients with metastatic disease surviving >2 years. . …
BACKGROUND: recent decades have seen combination chemoradiotherapy become the standard treatment for anal squamous cell carcinoma (SC …
Immune-checkpoint inhibitors in anal squamous cell carcinoma: a systematic review and meta-analysis.
Pala L, De Pas T, Stucchi E, Catania C, Cocorocchio E, Zampino MG, Rossi G, Zattarin E, Di Muzio A, Laszlo D, Stucchi S, Conforti F. Pala L, et al. Semin Oncol. 2023 Dec;50(6):140-143. doi: 10.1053/j.seminoncol.2023.11.002. Epub 2023 Nov 24. Semin Oncol. 2023. PMID: 38065801 Review.
INTRODUCTION: Squamous cell carcinoma of the anus (SCCA) is a rare tumor. While most patients with locally advanced disease are cured with chemo-radiotherapy, about a quarter eventually experience metastatic recurrence. ...METHODS: We systematically searched PubMed, …
INTRODUCTION: Squamous cell carcinoma of the anus (SCCA) is a rare tumor. While most patients with locally advanced disease are cured …
Outcome following local excision of T1 anal cancers-a systematic review.
Pedersen TB, Kildsig J, Serup-Hansen E, Gocht-Jensen P, Klein MF. Pedersen TB, et al. Int J Colorectal Dis. 2020 Sep;35(9):1663-1671. doi: 10.1007/s00384-020-03687-8. Epub 2020 Jul 15. Int J Colorectal Dis. 2020. PMID: 32671458 Review.
PURPOSE: In most cases, squamous cell carcinoma of the anus (SCCA) is treated with chemo-radiotherapy preserving sphincter function and offering good long-term survival and low recurrence rates. ...CONCLUSION: The current literature on outcome following local excision of T …
PURPOSE: In most cases, squamous cell carcinoma of the anus (SCCA) is treated with chemo-radiotherapy preserving sphincter function a …
[(18)F]-FDG PET in anal canal cancer: a systematic review and meta-analysis.
Mirshahvalad SA, Mesci A, Murad V, Kohan A, Ortega C, Veit-Haibach P, Metser U. Mirshahvalad SA, et al. Eur J Nucl Med Mol Imaging. 2023 Dec;51(1):258-277. doi: 10.1007/s00259-023-06393-z. Epub 2023 Aug 18. Eur J Nucl Med Mol Imaging. 2023. PMID: 37592085 Review.
PURPOSE: To provide comprehensive data on the diagnostic and prognostic value of [(18)F]-FDG PET (PET) in anal canal cancer patients. METHODS: This study was designed following the PRISMA-DTA guidelines. ...Conversely, for those achieving complete metabolic response …
PURPOSE: To provide comprehensive data on the diagnostic and prognostic value of [(18)F]-FDG PET (PET) in anal canal cancer pa …
Optimal surgical management strategy for treatment of primary anorectal malignant melanoma-a systematic review and meta-analysis.
Temperley HC, O'Sullivan NJ, Keyes A, Kavanagh DO, Larkin JO, Mehigan BJ, McCormick PH, Kelly ME. Temperley HC, et al. Langenbecks Arch Surg. 2022 Dec;407(8):3193-3200. doi: 10.1007/s00423-022-02715-1. Epub 2022 Nov 4. Langenbecks Arch Surg. 2022. PMID: 36331615 Review.
BACKGROUND: Primary mucosal anorectal malignant melanoma (AMM) is an invasive malignancy with poor survival. ...The outcomes of interest were the impact that surgical strategy had on survival (primary) and recurrence rates (secondary) for the treatment of AMM, compa …
BACKGROUND: Primary mucosal anorectal malignant melanoma (AMM) is an invasive malignancy with poor survival. ...The outcomes of inter …
Chemotherapy/chemoradiation in anal cancer: a systematic review.
Lim F, Glynne-Jones R. Lim F, et al. Cancer Treat Rev. 2011 Nov;37(7):520-32. doi: 10.1016/j.ctrv.2011.02.003. Epub 2011 Mar 29. Cancer Treat Rev. 2011. PMID: 21450408 Review.
AIMS: This systematic review examines evidence for efficacy and toxicity of chemotherapy and chemoradiotherapy in anal cancer. RESULTS: In total, for chemoradiation, 103 retrospective/observational studies, four phase I/II studies, 16 phase II prospective studies, two rand …
AIMS: This systematic review examines evidence for efficacy and toxicity of chemotherapy and chemoradiotherapy in anal cancer. RESULT …
The Role of FDG-PET in the Initial Staging and Response Assessment of Anal Cancer: A Systematic Review and Meta-analysis.
Jones M, Hruby G, Solomon M, Rutherford N, Martin J. Jones M, et al. Ann Surg Oncol. 2015 Oct;22(11):3574-81. doi: 10.1245/s10434-015-4391-9. Epub 2015 Feb 5. Ann Surg Oncol. 2015. PMID: 25652048 Review.
PURPOSE: The aim of this systematic review and meta-analysis was to compare the role of FDG-positron emission tomography (PET) or PET/computed tomography (CT) with conventional imaging in the detection of primary and nodal disease in anal cancer, and to assess the impact o …
PURPOSE: The aim of this systematic review and meta-analysis was to compare the role of FDG-positron emission tomography (PET) or PET/comput …
Chromosomal gains and losses in human papillomavirus-associated neoplasia of the lower genital tract - a systematic review and meta-analysis.
Thomas LK, Bermejo JL, Vinokurova S, Jensen K, Bierkens M, Steenbergen R, Bergmann M, von Knebel Doeberitz M, Reuschenbach M. Thomas LK, et al. Eur J Cancer. 2014 Jan;50(1):85-98. doi: 10.1016/j.ejca.2013.08.022. Epub 2013 Sep 17. Eur J Cancer. 2014. PMID: 24054023 Review.
BACKGROUND: Overexpression of the human papillomavirus (HPV) oncogenes E6 and E7 is necessary for the development of distinct lower genital tract cancers. However, secondary cellular genomic alterations are mandatory to promote progression of HPV-induced premalignant stage …
BACKGROUND: Overexpression of the human papillomavirus (HPV) oncogenes E6 and E7 is necessary for the development of distinct lower genital …
22 results